|
1. Heit HA. Addiction physical dependence and tolerance: precise definitions to help clinicians evaluate and treat chronic pain patients. J Pain Pall Care Pharmacother 2003; 17:15-29. doi.10.1080/j354v17n01_03. 2. Kendler KS, Jacobson KC, Prescott CA, Neale MC. Specificity of genetic and environmental risk factors for use and abuse dependence of cannabis cocaine hallucinogens sedatives stimulants and opiates in male twins. Am J Psychiatr 2003;160: 687-95. doi.10.1176/appi.ajp.160.4.687. 3. Goldman D, Oroszi G, Ducci F. The genetics of addictions uncovering the genes. Nat Rev Genet 2005; 6:521-32. doi.10.1038/nrg1635. 4. Kulsudjarit K. Drug problem in southeast and southwest Asia. Ann N Y Acad Sci 2004; 1025:446 -57. doi.10.1196/annals.1316.055. 5. Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res 2000; 126: 325-41. doi. 10.1016/S0079-6123(00)26022-6. 6. Yeh TL, Chen KC, Lin SH, Lee IH, Chen PS, Yao WJ, et al. Availability of dopamine and serotonin transporters in opioid dependent users--a two-isotope SPECT study. Psychopharmacology 2012; 220: 55-64. doi.10.1007/s00213-011-2454-6. 7. Saiz PA, Garciaportilla MP, Florez G, Arango C, Corcoran P, Morales B, et al. Differential role of serotonergic polymorphisms in alcohol and heroin dependence. Prog Neuropsychopharmacol Biol Psychiatr 2009; 15: 695-700. doi. 10.1016/j.pnpbp.2009.03.016. 8. Akimova E, Lanzenberger R, Kasper S. The serotonin 1a receptor in anxiety disorders. Biol Psychiatr2009; 66: 627-35. doi.10.1016/j.biopsych.2009.03.012. 9. Kaye WH, Frank GK, Bailer UF, Henry SE, Meltzer CC, Price JC, et al. Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies. Physiol Behave 2005; 85:73-81. doi.10.1016/j.physbeh.2005.04.013. 10. Grubor M, Zivkovic M, Sagud M, Perkovic MN, Mihaljevicpeles A, Pivac N, et al. Htr1a ana htr1b and htr2a and htr2c and htr6 gene polymorphisms and extrapyramidal side effects in haloperidol treated patients with schizophrenia. Int J Mol Sci 2020; 28:2345. doi. 10.3390/ijms21072345. 11. Kirby LG, Zeeb FD, Winstanley CA. Contributions of serotonin in addiction vulnerability. Neuropharmacology 2011; 61: 421-32. doi.10.1016/j.neuropharm.2011.03.022. 12. Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav 2002;71:533-54. doi.10.1016/s0091-3057(01)00746-8. 13. Reynolds GP, McGowan OO, Dalton CF. Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms. Br J Clin Pharmacol 2014; 77:654-72. doi.10.1111/bcp.12312. 14. Pandey SC, Davis JM, Pandey GN. Phosphoinositide systemlinked serotonin receptor subtypes and their pharmacological properties and clinical correlates. J Psychiatr Neurosci 1995; 20:215-25. 15. Cao J, Liu X, Han S, Zhang C K, Liu Z, Li D. Association of the htr2a gene with alcohol and heroin abuse. Hum Genet 2014; 133: 357-65. doi.10.1007/s00439-013-1388-y. 16. Polesskaya OO, Sokolov BP. Differential expression of the C and T alleles of the 5‐ht2a receptor gene in the temporal cortex of normal individuals and schizophrenics. J Neurosci Res 2002; 15:812-22. doi.10.1002/jnr.10173. 17. Li Y, Shi X, Cai X, Zhu Y, Chen Y, Lai J. MicroRNA422a inhibits dcc expression in a manner dependent on snp rs12607853. 18. Cytogenet Genome Res 2020; 160:3-71. doi. 10.1159/000506031. 19. Polesskaya OO, Aston C, Sokolov BP. Allele C‐specific methylation of the 5‐ht2a receptor gene evidence for correlation with its expression and expression of DNA methylase dnmt1. J Neurosci Res 2006; 15:362-73. doi.10.1002/jnr.20732. 20. Fehr C, Schleicher A, Szegedi A, Anghelescu I, Klawe C, Hiemke C, et al. Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy. Prog Neuropsychopharmacol Biol Psychiatr 2001; 25: 965-82. doi.10.1016/s0278-5846(01)00171-3. 21. Jakubczyk A, Klimkiewicz A, Kopera M, Krasowska A, Wrzosek M, Matsumoto H, et al. The cc genotype in the t102c htr2a polymorphism predicts relapse in individuals after alcohol treatment. J Psychiatr Res 2013; 47: 527-33. doi: 10.1016/j.jpsychires.2012.12.004. 22. Tsunoka T, Kishi T, Kitajima T, Okochi T, Okumura T, Yamanouchi Y, et al. Association analysis of grm2 and htr2a with methamphetamine induced psychosis and schizophrenia in the Japanese population. Prog Neuropsychopharmacol Biol Psychiatr 2010; 30:639-44. doi.10.1016/j. pnpbp.2010.03.002. 23. Hwu HG, Chen CH. Association of 5HT2A receptor gene polymorphism and alcohol abuse with behavior problems. Am J Med Genet 2000; 4:797-800. doi. 10.1002/1096-8628(20001204)96:6<797: aid-ajmg20>3.0.co;2-k.
|
